ArticleCureus2025
Coexistence of Adult-Onset Still's Disease and Graves' Disease: Coincidence or Continuum?
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adult-onset Still's disease (AOSD) is a rare systemic autoimmune disorder of unclear etiology, typically characterized by prolonged fever, arthralgia, transient rash, and leukocytosis. Graves' disease (GD) is a common autoimmune cause of hyperthyroidism in young adults. Although associations between autoimmune conditions have been reported, the coexistence of AOSD and GD remains uncommon. We describe the case of a 22-year-old patient presenting with clinical and biochemical hyperthyroidism, confirmed by thyroid scintigraphy. The clinical picture was further complicated by persistent inflammatory syndrome, marked hyperferritinemia, and hepatosplenomegaly, consistent with AOSD as defined by Yamaguchi's criteria. The disease course was characterized by recurrent inflammatory flares of both conditions and the development of carbimazole-induced hepatocellular injury, necessitating discontinuation of the drug and subsequent radioiodine ablation. The patient was also treated with corticosteroid therapy, leading to favorable clinical and laboratory improvement. Several reports have documented the association between AOSD and GD, suggesting a potential shared pathophysiological basis. Both conditions exhibit genetic susceptibility linked to HLA-DRB1 alleles and share immune dysregulation driven by excessive cytokine production, particularly interleukin-18, tumor necrosis factor-α, and interferon-γ. This molecular overlap may account for their coexistence in some patients, regardless of sex. Systematic screening for thyroid dysfunction is advisable in patients with AOSD, irrespective of gender, in order to better identify this underrecognized association.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.